News

Accord will donate the tablets, along with the same number of matched placebo, to the global COPCOV study. The study is assessing the use of chloroquine and hydroxychloroquine in the prevention of Covid-19 in healthcare settings. The study involves...

Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK diagnostic testing laboratories and facilities in the coming weeks and months. The portal enables scientists...

N4 Pharma Plc , the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces that it will be undertaking a proof of concept research project using a Covid-19 DNA plasmid for the purpose...

Electronic laboratory notebook (ELN) pioneer, BioData announces its support for the global science community with the introduction of a new video conferencing service in its leading Labguru ELN platform, free of charge for all customers.  The new LabRoom tool facilitates live global collaboration, experiment planning...

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St George’s, University of London. The availability of...

Cobra Biologics and the Karolinska Institutet (KI) have been awarded €3 million in emergency funding to take a DNA vaccine for Covid-19 through phase I clinical trial testing. The funding, awarded by Horizon 2020, comes as part of the OPENCORONA...

Only time will tell if any of the assays, medical equipment or drugs the U.S. FDA is approving for use during the COVID-19 pandemic under Emergency Use Authorization (EUA) will turn out to be ineffective or substandard. Now, the...